http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#Head http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#assertion http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#provenance http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#pubinfo http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#assertion http://purl.obolibrary.org/obo/DOID_289 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_289 http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00717 http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#association http://www.w3.org/2000/01/rdf-schema#label aygestin norethindrone acetate tablets usp is indicated for the treatment of secondary amenorrhea endometriosis and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology such as submucous fibroids or uterine cancer aygestin norethindrone acetate tablets usp is not intended recommended or approved to be used with concomitant estrogen therapy in postmenopausal women for endometrial protection http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00717 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#provenance http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#pubinfo http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#sig http://purl.org/nanopub/x/hasSignature H0VeovxusxThqRp1pbnlm62fLTBPz1F0L+C6P+HD9eiYgzwG8EY2bPQ/x5OPNtbz4AmVyua86Ss39eEg/3qNZetO4V0AXTA6GmQ1B4PTkbDNWbNZXqz3FQRFzjXbHikOYyhKJ9uWdB0t/gw5UMJ5ppFczSR3iwzCITqB4l8D360= http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI http://purl.org/dc/terms/created 2021-07-03T11:41:55.828+02:00 http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RA-7rUfsF0o0FuzcfI1z6X-1x8-ijtDXqf-AGOGAVGHfI https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs